Cardiac
Markers
Cardiac injury is a common pathological condition in clinical practice and may result from ischemia or damage to myocardial tissue. It is associated with conditions such as acute myocardial infarction, angina, myocarditis, heart failure, and other cardiovascular disorders. Cardiac injury may present with symptoms including chest pain, shortness of breath, fatigue, and impaired cardiac function, often accompanied by systemic changes such as elevated cardiac biomarker levels. By measuring cardiac marker concentrations, KSB cardiac assays support the evaluation of myocardial injury status and assist in the clinical assessment, screening, monitoring, and management of cardiac-related conditions.
VeriGoldTM
Gold-Conjugated Immunoassay
VeriLumenTM Fluorescence Immunoassay
Cardiac injury is a major pathological condition encountered in clinical practice and may result from myocardial ischemia or direct damage to heart tissue. It is commonly associated with cardiovascular disorders such as acute myocardial infarction, angina pectoris, myocarditis, heart failure, and other forms of cardiac dysfunction. These conditions can significantly impair cardiac performance and may rapidly progress if not properly diagnosed and managed, making early identification of myocardial damage clinically essential.
Clinically, cardiac injury may present with symptoms including chest pain, shortness of breath, fatigue, palpitations, and reduced exercise capacity, all reflecting impaired cardiac function. In many cases, these symptoms are accompanied by biochemical changes in the blood, particularly elevated cardiac biomarker levels that indicate myocardial stress or injury. Monitoring these changes is important for early detection, risk stratification, and guiding timely therapeutic intervention in acute and chronic cardiovascular conditions.
Cardiac markers can be measured in biological samples such as whole blood, serum, and plasma, depending on the specific analyte and intended clinical use. Their detection is commonly performed using immunological and biochemical methods designed to provide high sensitivity, specificity, and reproducibility. Among these, immunoassay-based technologies are widely used in clinical diagnostics due to their reliability, rapid performance, and compatibility with standardized laboratory and point-of-care workflows.
Explore
Your
Options
深圳市康生保
生物技术有限公司
深圳市宝安区
福海 街道
新和 社区 安达
电子厂区3栋2楼
518103
+86 0755 27417763
info@ksbbiotech.com